Redefining Lab Experiences: A Conversation with LabOS

In today’s fast-evolving healthcare landscape, no single company can meet the
demands of modern diagnostics alone. That’s why partnerships between best-in-
class platforms are driving the next wave of transformation.
At the intersection of lab efficiency and patient experience, LabOS and
PreciseMDX have joined forces to offer a seamless, end-to-end solution for
laboratories, providers, and patients alike.
In this interview, Gilad Brand, CBDO at LabOS, will share the story behind the
collaboration, the challenges, and what this partnership means for the future of
lab technology.

1. To start off, tell us briefly who you are and what your company does.
LabOS was founded in 1989 by Efy Brand, with a clear mission: to simplify the
complexity of medical lab operations and build smarter, more automated systems
that actually work for the people using them. It began with local major HMOs and
hospitals and later expanded globally in 2001 – growing steadily through word of
mouth and real-world performance, not hype.
Today, LabOS supports labs across all clinical fields; from microbiology and
digital pathology to genetics and anatomic pathology, to name just a few, with a
platform designed for flexibility, speed, and real-time integration. It’s fully cloud-
based, highly configurable, and built to adapt to each lab’s specific environment,
whether that’s a single-site operation or a national network.
At its core, LabOS exists to reduce friction. We connect systems, simplify
workflows, and give labs more control over their operations, so they can focus on
delivering better diagnostics and patient care – not wrestling with outdated tech.

2. What problems are you solving in the healthcare and diagnostics
ecosystem?
In many diagnostic labs today, the systems meant to support operations actually
slow them down. Data lives in silos, processes are fragmented, and making even

small changes requires weeks of technical work. That’s a big problem in a world
where accuracy, speed, and adaptability aren’t nice-to-haves – they’re essential.
LabOS was built to address that. We’re solving the fundamental issue of rigidity
in Laboratory Information Systems. Our platform gives labs the freedom to evolve
– to integrate with new tools, customize workflows and tailor-made dashboards,
scale across locations, and make operational changes without heavy IT
involvement.
The result is a more agile, data-connected lab that can keep pace with medical,
regulatory, and business demands, instead of constantly playing catch-up.

3. LabOS has become known as a highly flexible and scalable LIS – what
sets your platform apart from others in the market?
The sad truth is that a lot of LIS platforms claim to be flexible or scalable, but in
practice, most are built on rigid structures that make true customization
expensive, slow, or impossible without vendor intervention.
What sets LabOS apart is that flexibility and scalability aren’t features we added
on – they’re inherent in the architecture from the start.
We’ve designed LabOS so labs can shape the system around their workflows,
not the other way around. Whether it’s configuring tests, integrating with
instruments or third-party systems, supporting multi-site operations, or adapting
to new regulatory needs – changes can be made without rewriting code or
disrupting operations.
It’s not just about being cloud-based. It’s about control. Labs using LabOS aren’t
stuck waiting on IT teams or vendors to keep up with change; they’re in the
driver’s seat.

4. How do you approach innovation in lab workflows, especially when
balancing compliance and complexity?

We approach innovation by starting with one principle: flexibility is only useful if
it’s also safe. In a lab setting, every workflow touches regulated data, so any
change (whether operational or technical) needs to be traceable, validated, and
auditable by design.
That’s why LabOS is built with a layered architecture: core functions are
governed and locked down, while workflows, logic rules, validations, and
integrations are configurable at the application level. This gives labs the ability to
innovate locally – adapt processes, launch new services, and automate manual
steps, without compromising compliance or requiring source code changes.
We also emphasize structured data flow. From sample intake to final reporting,
every step is standardized and logged, enabling real-time monitoring, audit trails,
and quality checks. So even as complexity grows, oversight doesn’t break down.
In short, we make it possible for labs to move fast, but within a framework that
supports accountability, transparency, and control.

5. How did the partnership between LabOS and PreciseMDX start, and what
sparked the initial collaboration?
The collaboration started in a pretty organic way – one of our customers,
Sherman Abrams Labs, met PreciseMDX at an industry event and thought there
was real value in connecting us. From that introduction, it quickly became clear
that we shared a common approach: helping labs streamline operations by
removing friction between systems. That initial conversation grew into a
partnership built on complementary strengths, as PreciseMDX handles the
patient-facing digital experience, and LabOS powers the operational engine on
the backend.

6. What is the value of this integration to your shared customers – labs,
clinicians, and patients?

The value of this integration is simple and highly effective, as labs get the best of
both worlds: a highly advanced, flexible, and customizable LIS platform from

LabOS, and a smart, patient-friendly digital layer that is PreciseMDX, which
simplifies and digitizes much of the old-fashioned paperwork. For shared
customers, this means fewer manual steps, fewer errors, and faster turnaround
times. They get the best possible LIS solution, with the future-ready addition of
PreciseMDX’s solution.
A good example is digital order entry – instead of staff manually entering forms,
PreciseMDX captures and structures the data automatically, feeding it directly
into LabOS. That reduces administrative overhead and speeds up lab
processing. So, clinicians get results sooner, patients get a much smoother
experience, and labs operate more efficiently, with less room for mistakes.

7. What’s next for this partnership? Any exciting developments or goals
you’re aiming for together?

The partnership is already creating a meaningful impact – combining LabOS’
powerful backend capabilities with PreciseMDX’s intuitive digital experience.
Labs are already recognizing the value of our unified solution, which combines
operational depth with a seamless digital experience.
Looking ahead, we're focused on scaling this value even further: reaching more
labs, accelerating onboarding, and delivering a unified, modern workflow to labs
that want to modernize, scale, and deliver better service across the board – from
intake to diagnosis and delivery.
Together, we're setting a new standard for what a connected, efficient, and
patient-centered lab experience can look like.